Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
Increase in nitric oxide and cyclic GMP of rat cerebellum by radio frequency burst-type electromagnetic field radiation.
Miura M
,
Takayama K
,
Okada J
.
???displayArticle.abstract???
1. Using rat cerebellum supernatant, the effects of radio frequency (RF) burst-type electromagnetic (EM) field radiation on the production of cyclic GMP were examined under various conditions. The radiation was generated by a generator coil, and set at a 10 MHz radiation frequency, a 50% burst time, a 10 kHz burst rate and a 5 V peak-to-peak generator voltage. 2. When the cerebellum supernatant was incubated with both exogenous L-arginine (nitric oxide (NO) donor) and NADPH, and irradiated by an RF burst-type EM field, the production of cyclic GMP was increased significantly from a level of 21-22 nmol min-1 (g tissue)-1 to 25-26 nmol min-1 (g tissue)-1. By contrast, such an effect was not found when the cerebellum supernatant was irradiated by an RF volley-type EM field. 3. When neither L-arginine nor NADPH were added to the cerebellum supernatant, the production of cyclic GMP was lowered to a level of 6 nmol min-1 (g tissue)-1 and the radiation effect was not found. When the cerebellum supernatant was chelated with EDTA, the production of cyclic GMP was lowered to a level of 7 nmol min-1 (g tissue)-1 and the radiation effect was not found. 4. Incubation with Methylene Blue, a guanylate cyclase inhibitor, lowered the production of cyclic GMP to a level of 10-12 nmol min-1 (g tissue)-1, and the radiation effect did not occur. On incubation with a NO synthase inhibitor, either NG-methyl-L-arginine or N omega-nitro-L-arginine methyl ester, the production of cyclic GMP was lowered to a level of 10-12 nmol min-1 (g tissue)-1 or 5-9 nmol min-1 (g tissue)-1 respectively, and the radiation effect was not observed. 5. Using electrochemical NO probes, the production of NO in the cerebellum supernatant was detected. The concentration of NO increased gradually after the onset of the EM field radiation. The radiation effect persisted, and reached a maximum after the cessation of the radiation. 6. In an in vivo study, the arterioles of the frog web were dilated by the radiation, and this radiation effect was almost completely abolished by the addition of a NO synthase inhibitor. This indicates that radiation activates NO synthase and ultimately induces vasodilatation.
BELL,
Determination of the oil/water distribution coefficients of glyceryl trinitrate and two similar nitrate esters.
1963, Pubmed
BELL,
Determination of the oil/water distribution coefficients of glyceryl trinitrate and two similar nitrate esters.
1963,
Pubmed
Bassett,
Augmentation of bone repair by inductively coupled electromagnetic fields.
1974,
Pubmed
Bredt,
Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum.
1989,
Pubmed
Bredt,
Localization of nitric oxide synthase indicating a neural role for nitric oxide.
1990,
Pubmed
Conti,
Reduced mitogenic stimulation of human lymphocytes by extremely low frequency electromagnetic fields.
1983,
Pubmed
Conti,
A role for Ca2+ in the effect of very low frequency electromagnetic field on the blastogenesis of human lymphocytes.
1985,
Pubmed
Corbin,
N-G-methylated arginines; a convenient preparation of N-G-methylarginine.
1974,
Pubmed
Desai,
Involvement of nitric oxide in the reflex relaxation of the stomach to accommodate food or fluid.
1991,
Pubmed
Fabiato,
Calculator programs for computing the composition of the solutions containing multiple metals and ligands used for experiments in skinned muscle cells.
1979,
Pubmed
Feelisch,
Correlation between nitric oxide formation during degradation of organic nitrates and activation of guanylate cyclase.
1987,
Pubmed
Garthwaite,
Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain.
1988,
Pubmed
Garthwaite,
NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices.
1989,
Pubmed
Green,
Activated macrophages destroy intracellular Leishmania major amastigotes by an L-arginine-dependent killing mechanism.
1990,
Pubmed
Gruetter,
Relationship between cyclic guanosine 3':5'-monophosphate formation and relaxation of coronary arterial smooth muscle by glyceryl trinitrate, nitroprusside, nitrite and nitric oxide: effects of methylene blue and methemoglobin.
1981,
Pubmed
Hidaka,
Stimulation of human platelet guanylate cyclase by unsaturated fatty acid peroxides.
1977,
Pubmed
Knowles,
Anti-inflammatory glucocorticoids inhibit the induction by endotoxin of nitric oxide synthase in the lung, liver and aorta of the rat.
1990,
Pubmed
Knowles,
Differential induction of brain, lung and liver nitric oxide synthase by endotoxin in the rat.
1990,
Pubmed
Knowles,
Formation of nitric oxide from L-arginine in the central nervous system: a transduction mechanism for stimulation of the soluble guanylate cyclase.
1989,
Pubmed
Kondo,
Simultaneous measurement of endothelium-derived relaxing factor by bioassay and guanylate cyclase stimulation.
1989,
Pubmed
Luben,
Effects of electromagnetic stimuli on bone and bone cells in vitro: inhibition of responses to parathyroid hormone by low-energy low-frequency fields.
1982,
Pubmed
Lyle,
Suppression of T-lymphocyte cytotoxicity following exposure to sinusoidally amplitude-modulated fields.
1983,
Pubmed
Miura,
Non-thermal vasodilatation by radio frequency burst-type electromagnetic field radiation in the frog.
1991,
Pubmed
,
Xenbase
Moore,
L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro.
1990,
Pubmed
Murphy,
Evidence for an astrocyte-derived vasorelaxing factor with properties similar to nitric oxide.
1990,
Pubmed
Palmer,
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
,
Pubmed
Palmer,
A novel citrulline-forming enzyme implicated in the formation of nitric oxide by vascular endothelial cells.
1989,
Pubmed
Radomski,
An L-arginine/nitric oxide pathway present in human platelets regulates aggregation.
1990,
Pubmed
Rees,
A specific inhibitor of nitric oxide formation from L-arginine attenuates endothelium-dependent relaxation.
1989,
Pubmed
Shibuki,
An electrochemical microprobe for detecting nitric oxide release in brain tissue.
1990,
Pubmed
Southam,
Comparative effects of some nitric oxide donors on cyclic GMP levels in rat cerebellar slices.
1991,
Pubmed
Volle,
Regulation of cyclic GMP levels in nerve tissue.
1983,
Pubmed
Vrolix,
Cyclic GMP-dependent protein kinase stimulates the plasmalemmal Ca2+ pump of smooth muscle via phosphorylation of phosphatidylinositol.
1988,
Pubmed
Wolin,
Methylene blue inhibits vasodilation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion.
1990,
Pubmed
Wuytack,
Evidence for the presence in smooth muscle of two types of Ca2+-transport ATPase.
1984,
Pubmed